OGN News and Press, Organon & Co. From 11/03/23

2023-11-03 10:42:01 ET Organon & Co ( NYSE: OGN ) has been downgraded by Goldman Sachs from Buy to Neutral after the Merck spinoff fell short of both top and bottom line expectations in its latest Q3 report . Revenue in women's health, Organon's biggest unit, fell 8% Y/Y...

2023-11-03 00:55:40 ET Summary SPDR S&P 600 Small Cap Value ETF is invested in over 400 small caps with a tilt to value over growth. It is well-diversified across sectors and holdings. The sector breakdown, valuation ratios and historical performance are not much different...

2023-11-02 13:29:17 ET Shares of Organon ( NYSE: OGN ) on Thursday slumped as much as 12.5% to a record low of $12.83, after the company saw a quarterly revenue decline in its main women's health business. Pharmaceutical giant Merck ( MRK ) spun-off Organon ( OGN ) i...

2023-11-02 12:21:05 ET Organon & Co (OGN) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Jennifer Halchak - VP, IR Kevin Ali - CEO Matthew Walsh - CFO Sandra Milligan - Head of R&D Conference Call Participants ...

2023-11-02 09:00:00 ET Summary Pfizer's stock has dropped due to a decline in revenues post-COVID, presenting a value investment opportunity. The company still generates significant gross profit and has a strong revenue growth rate. Pfizer's low Price-to-Earnings ratio and imp...

2023-11-02 07:31:27 ET More on Organon Organon: The Federal Reserve Black Swan (Rating Upgrade) 6% Yield And Significantly Undervalued: A Closer Look At Organon Organon Q2 2023 Earnings Review: Incremental Growth With A Slather Of Risk Organon Q3 2023 Earning...

Third quarter 2023 revenue of $1,519 million Third quarter 2023 diluted earnings per share of $0.23 and non-GAAP Adjusted diluted earnings per share of $0.87 Adjusted EBITDA of $447 million Board of Directors declares quarterly dividend of $0.28 per share Full year 2023 financial ...

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

Organon & Co. (OGN) is expected to report $1.04 for Q3 2023

2023-11-01 12:56:56 ET More on Organon Organon: The Federal Reserve Black Swan (Rating Upgrade) 6% Yield And Significantly Undervalued: A Closer Look At Organon Organon Q2 2023 Earnings Review: Incremental Growth With A Slather Of Risk Hennessy Funds is bulli...